{"lang": "en", "id": "1221866339419201543", "author_id": "1109479566945538049", "referenced_tweets": [{"type": "replied_to", "id": "1221840413700562944"}], "in_reply_to_user_id": "14499829", "possibly_sensitive": false, "reply_settings": "everyone", "created_at": "2020-01-27T18:43:31.000Z", "public_metrics": {"retweet_count": 0, "reply_count": 1, "like_count": 2, "quote_count": 0}, "text": "@WHO @WHOWPRO @WHOSEARO @WHO_Europe @pahowho @WHOEMRO @WHOAFRO Can someone qualified look into Angiotensin II receptor blockers as possible supportive medication? In theory they could make it more difficult for viruses to infect new cells. Side effects should be minimal since they can be given in lower doses compared to those used for HBP.", "source": "Twitter Web App", "entities": {"mentions": [{"start": 0, "end": 4, "username": "WHO", "id": "14499829"}, {"start": 5, "end": 13, "username": "WHOWPRO", "id": "3794682452"}, {"start": 14, "end": 23, "username": "WHOSEARO", "id": "1545915336"}, {"start": 24, "end": 35, "username": "WHO_Europe", "id": "125403342"}, {"start": 36, "end": 44, "username": "pahowho", "id": "20629893"}, {"start": 45, "end": 53, "username": "WHOEMRO", "id": "259372802"}, {"start": 54, "end": 62, "username": "WHOAFRO", "id": "544389588"}]}, "conversation_id": "1221800661039419398"}